Home health workers will join other low-wage workers in a nationwide rally Wednesday to demand that their employers pay a $15 minimum hourly wage.
UnitedHealth CEO Stephen Hemsley realized a potential gain of more than $45 million from exercising stock options last year, as the share price of the nation's largest health insurer topped $100 on the way to setting all-time highs.
One-fourth of tax-exempt healthcare organizations compensate independent board members, and 7% are considering doing so, according to a recent study.
Cone Health is seeing the benefit of its acquisition of Alamance Regional Medical Center after an integration period that raised expenses.
The Erlanger Health System board says it plans to hold a "do-over" meeting to discuss and vote again on $1.7 million in management bonuses that drew outrage from state lawmakers and prompted an attorney general's opinion.
For more than a decade, Beebe Healthcare, a 155-bed not-for-profit hospital in Lewes, Del., assigned executive compensation duties to the hospital board's executive committee. But more than a year ago, at the urging of a consultant, Beebe decided to make a change.
HCA, the country's largest hospital chain by revenue, reported a 41.9% increase in net income in the third quarter on higher revenue, prompting it to raise earnings projections for the full year.
Rich Roodman discusses his hospital's recent affiliation with University of Washington Medicine, his views on building good staff morale among his 3,000 employees and the criticism of his $1.4 million compensation package last year.
More than half a million U.S. physicians and 1,360 U.S. hospitals have financial relationships with medical device and drug companies, according to data released Tuesday under the Physician Payments Sunshine Act.
While the Sunshine Act was intended to help patients understand potential conflicts of interest in their care, some stakeholders fear the data may be used by government investigators and insurers tracking doctors' prescribing, surgical and other practice patterns.
With less than a week to go before the CMS unveils a new database describing payments made by industry to doctors and teaching hospitals, anxiety is high for the many people and organizations with their reputations on the line.
The research chief of GlaxoSmithKline said Wednesday that the British drug giant is becoming a more “open” organization, moving toward greater collaboration in developing medicines and building confidence with the public by halting payments to doctors for giving promotional talks about...